Tevogen Inc. (Nasdaq: TVGN) has regained compliance with Nasdaq's $50 million minimum market value of listed securities requirement for continued listing on The Nasdaq Global Market. The company received written confirmation from The Nasdaq Stock Market LLC on September 29, 2026, after previously clearing the minimum market value of publicly held shares requirement on September 9. Nasdaq-related compliance matters are now closed. Tevogen combines biotechnology, artificial intelligence, and healthcare services through Tevogen Bio, Tevogen.AI, and Tevogen Healthcare Services to pursue more affordable and accessible life-saving medicines.